Speaker: Chris Ryerson, MD, FRCPC, University of British Columbia, Vancouver, BC
Moderator: Julie Morisset, MD, FRCPC, Centre hospitalier de l’Université de Montréal , Montréal, QC

This presentation will present an overview of the historical approach to the management of interstitial lung disease and will then present the concept of a ‘treatable traits’ approach to the management of interstitial lung disease.

Learning Objectives
At the end of this presentation, attendees will be able to:

  • Provide an overview of the historical approach to the management of fibrotic interstitial lung disease;
  • List the advantages and limitations of a ‘treatable traits’ approach to the management of fibrotic interstitial lung disease; and
  • Apply a ‘treatable traits’ approach to the management of fibrotic interstitial lung disease to their patients.

CanMEDS Roles: Collaborator, Medical Expert, Professional, Scholar

This session is co-developed by the CTS and Boehringer-Ingelheim and is planned to achieve scientific integrity, objectivity and balance.